132 related articles for article (PubMed ID: 34150023)
21. Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer.
Ohnishi T; Hashizume C; Taniguchi M; Furumoto H; Han J; Gao R; Kinami S; Kosaka T; Okazaki T
FASEB J; 2017 Sep; 31(9):3816-3830. PubMed ID: 28522594
[TBL] [Abstract][Full Text] [Related]
22. GPRC5B-Mediated Sphingomyelin Synthase 2 Phosphorylation Plays a Critical Role in Insulin Resistance.
Kim YJ; Greimel P; Hirabayashi Y
iScience; 2018 Oct; 8():250-266. PubMed ID: 30343189
[TBL] [Abstract][Full Text] [Related]
23. Diacylglycerol kinase ΞΆ interacts with sphingomyelin synthase 1 and sphingomyelin synthase-related protein via different regions.
Furuta M; Murakami C; Numagami Y; Suzuki R; Sakane F
FEBS Open Bio; 2023 Jul; 13(7):1333-1345. PubMed ID: 37166445
[TBL] [Abstract][Full Text] [Related]
24. Discovery of 1,8-naphthyridin-2-one derivative as a potent and selective sphingomyelin synthase 2 inhibitor.
Yukawa T; Nakahata T; Okamoto R; Ishichi Y; Miyamoto Y; Nishimura S; Oikawa T; Kubo K; Adachi R; Satomi Y; Nakakariya M; Amano N; Kamaura M; Matsunaga N
Bioorg Med Chem; 2020 Apr; 28(7):115376. PubMed ID: 32088125
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous Multislice Accelerated Turbo Spin Echo Magnetic Resonance Imaging: Comparison and Combination With In-Plane Parallel Imaging Acceleration for High-Resolution Magnetic Resonance Imaging of the Knee.
Fritz J; Fritz B; Zhang J; Thawait GK; Joshi DH; Pan L; Wang D
Invest Radiol; 2017 Sep; 52(9):529-537. PubMed ID: 28430716
[TBL] [Abstract][Full Text] [Related]
26. Carboxyl-terminal Tail-mediated Homodimerizations of Sphingomyelin Synthases Are Responsible for Efficient Export from the Endoplasmic Reticulum.
Hayashi Y; Nemoto-Sasaki Y; Matsumoto N; Tanikawa T; Oka S; Tanaka Y; Arai S; Wada I; Sugiura T; Yamashita A
J Biol Chem; 2017 Jan; 292(3):1122-1141. PubMed ID: 27927984
[TBL] [Abstract][Full Text] [Related]
27. Deficiency of sphingomyelin synthase 2 prolongs survival by the inhibition of lymphoma infiltration through ICAM-1 reduction.
Taniguchi M; Ueda Y; Matsushita M; Nagaya S; Hashizume C; Arai K; Kabayama K; Fukase K; Watanabe K; Wardhani LO; Hayashi K; Okazaki T
FASEB J; 2020 Mar; 34(3):3838-3854. PubMed ID: 31970839
[TBL] [Abstract][Full Text] [Related]
28. Sphingomyelin in microdomains of the plasma membrane regulates amino acid-stimulated mTOR signal activation.
Zama K; Mitsutake S; Okazaki T; Igarashi Y
Cell Biol Int; 2018 Jul; 42(7):823-831. PubMed ID: 29369436
[TBL] [Abstract][Full Text] [Related]
29. Sphingomyelin synthase 2 overexpression promotes cisplatin-induced apoptosis of HepG2 cells.
Luo S; Pan Z; Liu S; Yuan S; Yan N
Oncol Lett; 2018 Jan; 15(1):483-488. PubMed ID: 29375716
[TBL] [Abstract][Full Text] [Related]
30. A sensitive cell-based method to screen for selective inhibitors of SMS1 or SMS2 using HPLC and a fluorescent substrate.
Zama K; Mitsutake S; Watanabe K; Okazaki T; Igarashi Y
Chem Phys Lipids; 2012 Oct; 165(7):760-8. PubMed ID: 23063490
[TBL] [Abstract][Full Text] [Related]
31. Discovery of the selective sphingomyelin synthase 2 inhibitors with the novel structure of oxazolopyridine.
Qi XY; Cao Y; Li YL; Mo MG; Zhou L; Ye DY
Bioorg Med Chem Lett; 2017 Aug; 27(15):3511-3515. PubMed ID: 28619536
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice.
Sugimoto M; Shimizu Y; Zhao S; Ukon N; Nishijima K; Wakabayashi M; Yoshioka T; Higashino K; Numata Y; Okuda T; Tamaki N; Hanamatsu H; Igarashi Y; Kuge Y
Biochim Biophys Acta; 2016 Aug; 1861(8 Pt A):688-702. PubMed ID: 27151272
[TBL] [Abstract][Full Text] [Related]
33. Sphingomyelin synthase 2 is palmitoylated at the COOH-terminal tail, which is involved in its localization in plasma membranes.
Tani M; Kuge O
Biochem Biophys Res Commun; 2009 Apr; 381(3):328-32. PubMed ID: 19233134
[TBL] [Abstract][Full Text] [Related]
34. Role and Function of Sphingomyelin Biosynthesis in the Development of Cancer.
D'Angelo G; Moorthi S; Luberto C
Adv Cancer Res; 2018; 140():61-96. PubMed ID: 30060817
[TBL] [Abstract][Full Text] [Related]
35. The sphingomyelin synthase family: proteins, diseases, and inhibitors.
Chen Y; Cao Y
Biol Chem; 2017 Nov; 398(12):1319-1325. PubMed ID: 28742512
[TBL] [Abstract][Full Text] [Related]
36. Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1.
Deevska GM; Dotson PP; Karakashian AA; Isaac G; Wrona M; Kelly SB; Merrill AH; Nikolova-Karakashian MN
J Biol Chem; 2017 Mar; 292(12):5110-5122. PubMed ID: 28087695
[TBL] [Abstract][Full Text] [Related]
37. The effect of sphingomyelin synthase 2 (SMS2) deficiency on the expression of drug transporters in mouse brain.
Zhang Y; Dong J; Zhu X; Wang W; Yang Q
Biochem Pharmacol; 2011 Aug; 82(3):287-94. PubMed ID: 21554861
[TBL] [Abstract][Full Text] [Related]
38. A facile method for monitoring sphingomyelin synthase activity in HeLa cells using liquid chromatography/mass spectrometry.
Sundaraswamy PM; Minami Y; Jayaprakash J; B Gowda SG; Takatsu H; Gowda D; Shin HW; Hui SP
Analyst; 2024 Jun; 149(12):3293-3301. PubMed ID: 38713069
[TBL] [Abstract][Full Text] [Related]
39. Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells.
Yan N; Ding T; Dong J; Li Y; Wu M
Lipids Health Dis; 2011 Mar; 10():46. PubMed ID: 21418611
[TBL] [Abstract][Full Text] [Related]
40. [Sphingomyelin synthase 2 deficiency decreases atherosclerosis and inhibits inflammation in mice].
Qin R; Chen ML; Zhu K; Deng JB; Shi YY
Sheng Li Xue Bao; 2010 Aug; 62(4):333-8. PubMed ID: 20717634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
